Cite
Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial.
MLA
Shuaib A, et al. “Partial Aortic Occlusion for Cerebral Perfusion Augmentation: Safety and Efficacy of NeuroFlo in Acute Ischemic Stroke Trial.” Stroke (00392499), vol. 42, no. 6, June 2011, pp. 1680–90. EBSCOhost, https://doi.org/10.1161/STROKEAHA.110.609933.
APA
Shuaib A, Bornstein NM, Diener HC, Dillon W, Fisher M, Hammer MD, Molina CA, Rutledge JN, Saver JL, Schellinger PD, Shownkeen H, SENTIS Trial Investigators, Shuaib, A., Bornstein, N. M., Diener, H.-C., Dillon, W., Fisher, M., Hammer, M. D., Molina, C. A., & Rutledge, J. N. (2011). Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial. Stroke (00392499), 42(6), 1680–1690. https://doi.org/10.1161/STROKEAHA.110.609933
Chicago
Shuaib A, Bornstein NM, Diener HC, Dillon W, Fisher M, Hammer MD, Molina CA, et al. 2011. “Partial Aortic Occlusion for Cerebral Perfusion Augmentation: Safety and Efficacy of NeuroFlo in Acute Ischemic Stroke Trial.” Stroke (00392499) 42 (6): 1680–90. doi:10.1161/STROKEAHA.110.609933.